TCL Archive Letter to the Editors: BSA P01 Review Vote Was Advisory, NCI Official Says December 5, 1997
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive Private Institute Commits $1 Million Pick Up some NIH Grants Left Unfunded April 19, 1985
